Moderna Inc. has become the frontrunner in the race to develop a vaccine against COVID-19 as its candidate is set to enter Phase III clinical trials next month. The status puts further pressure on the company to be able to supply billions of doses to people around the world.
Moderna CEO Stéphane Bancel described what the company is doing to scale up production of its mRNA vaccine candidate at...







